Risk of developing depression from endocrine treatment: A nationwide cohort study of women administered treatment for breast cancer in South Korea

Risk of developing depression from endocrine treatment: A nationwide cohort study of women administered treatment for breast cancer in South Korea

BackgroundAlthough previous studies demonstrated no association between depression and tamoxifen in patients with breast cancer, there is still a limited amount of long-term follow-up data. This study aimed to evaluate the relationship between endocrine treatment and the risk of depression.MethodsTh...

Full description

Bibliographic Details
Main Authors: Jooyoung Oh, Hye Sun Lee, Soyoung Jeon, Dooreh Kim, Jeong-Ho Seok, Woo-Chan Park, Jae-Jin Kim, Chang Ik Yoon
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
breast cancer
endocrine treatment
tamoxifen
aromatase inhibitor
depression
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.980197/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.980197/full

Similar Items